141 related articles for article (PubMed ID: 36370473)
21.
Pfannkuchen N; Bausbacher N; Pektor S; Miederer M; Rosch F
Curr Radiopharm; 2018; 11(3):223-230. PubMed ID: 29866026
[TBL] [Abstract][Full Text] [Related]
22. Development of a transmission alpha particle dosimetry technique using A549 cells and a Ra-223 source for targeted alpha therapy.
Al Darwish R; Staudacher AH; Li Y; Brown MP; Bezak E
Med Phys; 2016 Nov; 43(11):6145. PubMed ID: 27806616
[TBL] [Abstract][Full Text] [Related]
23. Clinical trials of targeted alpha therapy for cancer.
Allen BJ
Rev Recent Clin Trials; 2008 Sep; 3(3):185-91. PubMed ID: 18782076
[TBL] [Abstract][Full Text] [Related]
24. Radionuclide antibody-conjugates, a targeted therapy towards cancer.
Kitson SL; Cuccurullo V; Moody TS; Mansi L
Curr Radiopharm; 2013 Jun; 6(2):57-71. PubMed ID: 23808764
[TBL] [Abstract][Full Text] [Related]
25. Alpha particles as radiopharmaceuticals in the treatment of bone metastases: mechanism of action of radium-223 chloride (Alpharadin) and radiation protection.
Cheetham PJ; Petrylak DP
Oncology (Williston Park); 2012 Apr; 26(4):330-7, 341. PubMed ID: 22655525
[TBL] [Abstract][Full Text] [Related]
26. A Monte Carlo Investigation of Dose Point Kernel Scaling for α-Emitting Radionuclides.
Khan AU; DeWerd LA
Cancer Biother Radiopharm; 2021 Apr; 36(3):252-259. PubMed ID: 33337280
[No Abstract] [Full Text] [Related]
27. Use of Gaussian-type functions for flux-based dose calculations in carbon ion therapy.
Usta M; Aydın G
Radiat Environ Biophys; 2020 Aug; 59(3):511-522. PubMed ID: 32561981
[TBL] [Abstract][Full Text] [Related]
28. Monte Carlo simulation of age-dependent radiation dose from alpha- and beta-emitting radionuclides to critical trabecular bone and bone marrow targets.
Dant JT; Richardson RB; Nie LH
Phys Med Biol; 2013 May; 58(10):3301-19. PubMed ID: 23615276
[TBL] [Abstract][Full Text] [Related]
29. Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions.
Bouchet LG; Bolch WE; Goddu SM; Howell RW; Rao DV
J Nucl Med; 2000 Apr; 41(4):682-7. PubMed ID: 10768569
[TBL] [Abstract][Full Text] [Related]
30. Targeted alpha therapy with
Ackerman NL; de la Fuente Rosales L; Falzone N; Vallis KA; Bernal MA
Phys Med; 2018 Jul; 51():91-98. PubMed ID: 29807854
[TBL] [Abstract][Full Text] [Related]
31. Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-dichloride.
Pandit-Taskar N; Larson SM; Carrasquillo JA
J Nucl Med; 2014 Feb; 55(2):268-74. PubMed ID: 24343987
[TBL] [Abstract][Full Text] [Related]
32. Development of Targeted Alpha Particle Therapy for Solid Tumors.
Tafreshi NK; Doligalski ML; Tichacek CJ; Pandya DN; Budzevich MM; El-Haddad G; Khushalani NI; Moros EG; McLaughlin ML; Wadas TJ; Morse DL
Molecules; 2019 Nov; 24(23):. PubMed ID: 31779154
[TBL] [Abstract][Full Text] [Related]
33. Alpha-particle microdosimetry.
Chouin N; Bardies M
Curr Radiopharm; 2011 Jul; 4(3):266-80. PubMed ID: 22201713
[TBL] [Abstract][Full Text] [Related]
34. Innovation, Impact, and Strategic Importance of Alpha-Emitting Radionuclides.
Mirzadeh S
J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S21-S25. PubMed ID: 31420270
[TBL] [Abstract][Full Text] [Related]
35. A comparative evaluation of Ac225 vs Bi213 as therapeutic radioisotopes for targeted alpha therapy for cancer.
Allen BJ
Australas Phys Eng Sci Med; 2017 Jun; 40(2):369-376. PubMed ID: 28342027
[TBL] [Abstract][Full Text] [Related]
36. Radiation-based approaches for therapy and palliation of advanced prostate cancer.
Lewis B; Sartor O
Curr Opin Urol; 2012 May; 22(3):183-9. PubMed ID: 22453334
[TBL] [Abstract][Full Text] [Related]
37. High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?
Bruland ØS; Nilsson S; Fisher DR; Larsen RH
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6250s-6257s. PubMed ID: 17062709
[TBL] [Abstract][Full Text] [Related]
38. The Relationship Between Total Lesion Activity on
Filippi L; Basile P; Schillaci O; Bagni O
Cancer Biother Radiopharm; 2020 Aug; 35(6):398-403. PubMed ID: 32109140
[TBL] [Abstract][Full Text] [Related]
39. Dosimetry in targeted alpha therapy. A systematic review: current findings and what is needed.
Tronchin S; Forster JC; Hickson K; Bezak E
Phys Med Biol; 2022 Apr; 67(9):. PubMed ID: 35316802
[No Abstract] [Full Text] [Related]
40. Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle.
Dekempeneer Y; Keyaerts M; Krasniqi A; Puttemans J; Muyldermans S; Lahoutte T; D'huyvetter M; Devoogdt N
Expert Opin Biol Ther; 2016 Aug; 16(8):1035-47. PubMed ID: 27145158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
